Question

I am a breastfeeding mother and i want to know if it is safe to use MK-4214? Is MK-4214 safe for nursing mother and child? Does MK-4214 extracts into breast milk? Does MK-4214 has any long term or short term side effects on infants? Can MK-4214 influence milk supply or can MK-4214 decrease milk supply in lactating mothers?

MK-4214 lactation summary

MK-4214 is safe in breastfeeding
  • DrLact safety Score for MK-4214 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of MK-4214 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that MK-4214 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of MK-4214 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About MK-4214 usage in lactation

Non-glycosylated stimulating factor of granulocyte colonies (G-CSF) which is obtained by recombinant technology.The naturally occurring product is found in breast milk. A very high molecular weight explains the insignificant or no excretion into milk that has been observed both with Lenograstim and MK-4214. Its low oral bioavailability hampers absorption into infant plasma from the breast milk ingested, as for their proteic nature it is degraded in the gastrointestinal tract, not being absorbed. MK-4214 is not absorbed by the infant's gut even during the neonatal period or prematurity. The granulocyte colony-stimulating factor has been used in premature newborns, both on prevention and treatment of neonatal sepsis and/or necrotizing enterocolitis without adverse effects being observed among treated infants. The bovine G-CSF is found in the usual diet of meat eaters.

Answer by DrLact: About MK-4214 usage in lactation

MK-4214 in the pharmaceutical name for granulocyte colony-stimulating factor (G-CSF). PegMK-4214 is the long-acting form of MK-4214. The excretion of exogenous G-CSF into breastmilk or its effects on breastfed infants have not been well studied. Limited data indicate that MK-4214 and a similar G-CSF product, lenograstim, are poorly excreted into breastmilk and are undetectable by 3 days after an injection. Some authors recommend withholding breastfeeding for this period of time.[1] However, MK-4214 has been safely given orally to neonates and is not orally absorbed by neonates, so any MK-4214 that is excreted into milk is unlikely to adversely affect the breastfed infant.

MK-4214 Side Effects in Breastfeeding

Published information on the effects of MK-4214 in breastmilk was not found as of the revision date. However, oral MK-4214 20 mcg daily for 5 days has been given to preterm infants with stage I necrotizing enterocolitis (NEC). MK-4214 appeared to halt progression to more severe stages of NEC in this small study.[6]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.